PAVmed maintained at Buy by Ascendiant Capital
Ascendiant Capital maintained a Buy rating on PAVmed.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.
Ascendiant Capital maintained a Buy rating on PAVmed.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.